Bivalent Recombinant Protein Oil Vaccine
Number 361 - 1
Prevention of foot-and-mouth disease in pigs and cows
Concurrent prevention of foot-and-mouth disease serotype O and serotype A
2 mL at each inoculation per pig or cow
Primary inoculation is recommended on 8 weeks after birth in pigs and 4 months after birth in cows, intramuscularly.
Second inoculation must be performed in the same manner after 4 weeks of primary inoculation.
Inoculate every 6 months.
In the event of a foot-and-mouth disease breakout, additional immunization is recommended regardless of schedule.
Characteristics and AdvantagesPharoVax-FMD is a marker vaccine.
It is a vaccine that uses recombinant proteins as the immunogen, and cannot lead to any antibodies against non-structural proteins (NSP). Therefore, it is possible the differential diagnosis of animals that have been immunized by the vaccine or that have been infected by field virus.PharoVax-FMD can be easily optimized for each region or country.
Vaccines for newly mutated viral strains can be developed within 2 to 3 months. Also, one product can be expanded to defend against various serotypes or lineages of foot-and-mouth disease viruses. Therefore, optimized vaccines can be provided for various types of foot-and-mouth disease viruses adapted to specific countries or regions.